Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In a 56 week study conducted by the company responsible for the production of Saxenda, 3731 patients of varying backgrounds took part
Whats changed
Outcomes vary: Mild cases may improve with treatment Moderate cases may require long-term management Severe cases can become permanent Some patients develop lifelong GI dysfunction after GLP-1 drug use Early diagnosis significantly improves prognosis
Lili Ladaga Editor GLP-1 RA Prescription Trends: January 2018 March 2025
US$ 21.24
US$ 28.15
US$ 20.53
US$ 23.00
US$ 28.60
